Reuters logo
BRIEF-Finch Therapeutics, Takeda collaborate to develop microbiome therapeutics in inflammatory bowel disease
April 5, 2017 / 11:23 AM / 6 months ago

BRIEF-Finch Therapeutics, Takeda collaborate to develop microbiome therapeutics in inflammatory bowel disease

April 5 (Reuters) - Takeda Pharmaceutical Co Ltd

* Finch Therapeutics and Takeda announce global collaboration to develop microbiome therapeutics in inflammatory bowel disease (ibd)

* Takeda Pharmaceutical Co Ltd says under terms of agreement, Takeda will make an upfront payment of $10 million to Finch

* Takeda Pharmaceutical Co Ltd says further details of agreement were not disclosed

* Takeda Pharmaceutical - Finch will be eligible for development, regulatory, commercial financial milestones & tiered royalties on worldwide net sales Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below